Composition: Cyanocobalamin 1 mg/ml. Indication: Prevention and treatment of pernicious anemia. Betolvex is the highest technology in Vitamin B12 preparations, Providing fast onset and the longest duration of action, ensuring replenishment of Vitamin B12 body stores.
Composition: Iron hydroxide polymaltose 50mg/ml Indication: Enrich Oral Drops is prescribed for iron deficiency anemia.
Enrich Syrup is prescribed for iron deficiency anemia.
Composition: Human Recombinant Coagulation Factor VIII 500IU Indication: Nuwiq contains the active substance human recombinant coagulation factor VIII (simoctocog alfa). Factor VIII is necessary for the blood to form clots and stop bleeding. In patients with hemophilia A (inborn factor VIII deficiency), factor VIII is missing or not working properly. Nuwiq replaces the missing factor Vlll and is used for treatment and prevention of bleeding in patients with hemophilia A and can be used for all age groups
Composition: Human coagulation factor VIII 500IU Indication: Treatment and prevention of bleeding episodes in patients with hemophilia A (congenital or acquired FVIII deficiency), including previously treated patients (PTPs), previously untreated patients (PUPs) and patients undergoing major and minor surgical procedures; and for the treatment of inhibitors by Immune Tolerance Induction (ITI).
Composition: Human Coagulation Factor IX 500IU Indication: High-purity human Factor IX concentrate with two independent virus inactivation and removal steps (solvent/detergent treatment and nanofiltration) for the prophylaxis and treatment of bleeding in patients with hemophilia B.
Composition: Human prothrombin complex concentrate containing Factors II, VII, IX, X, as well as the inhibitor, protein C, and its cofactor protein S. Indication: Octaplex is used to treat and prevent bleeding caused by medicines called vitamin K antagonists (such as warfarin). Octaplex is used when rapid correction of the shortage is required in people born with a shortage of the vitamin K dependent clotting factors II and X. It is used when purified specific clotting factor product is not available.
Composition: 500 IU human coagulation Factor VIII Indication: Wilate belongs to the pharmacotherapeutic group of medicines called cloning factors and contains human blood coagulation factor VIII (FVIII) and von Willebrand factor (VWF). Together these two proteins are involved in blood clotting. Wilate is used to treat and prevent bleeding in patients with van Willebrand disease (VWD), which in fact is a family of related diseases. All types of W/0 are inborn. where bleeding can go on for longer than expected. This is either due to a lack of WIF in the blood or due to WJF that does not work the way it should. Wilate is used to treat and prevent bleeding in patients with hemophilia A. This is a condition in which bleeding can go on for longer than expected. It is due to an inborn lack of FVIII in the blood.
